Logo image of WALD

WALDENCAST PLC-A (WALD) Stock Fundamental Analysis

NASDAQ:WALD - Nasdaq - JE00BPG99318 - Common Stock - Currency: USD

3.16  -0.03 (-0.94%)

After market: 3.16 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to WALD. WALD was compared to 37 industry peers in the Personal Care Products industry. Both the profitability and financial health of WALD have multiple concerns. WALD is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

WALD had negative earnings in the past year.
WALD Yearly Net Income VS EBIT VS OCF VS FCFWALD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -20M -40M -60M -80M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -8.88%, WALD is doing worse than 69.44% of the companies in the same industry.
WALD has a Return On Equity (-14.55%) which is in line with its industry peers.
Industry RankSector Rank
ROA -8.88%
ROE -14.55%
ROIC N/A
ROA(3y)-7.83%
ROA(5y)N/A
ROE(3y)-12.54%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WALD Yearly ROA, ROE, ROICWALD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 0 0 0 0

1.3 Margins

With a Gross Margin value of 64.90%, WALD perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for WALD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.9%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WALD Yearly Profit, Operating, Gross MarginsWALD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 20 -20 40 -40 60 -60

2

2. Health

2.1 Basic Checks

WALD does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, WALD has more shares outstanding
Compared to 1 year ago, WALD has an improved debt to assets ratio.
WALD Yearly Shares OutstandingWALD Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 20M 40M 60M 80M 100M
WALD Yearly Total Debt VS Total AssetsWALD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

WALD has an Altman-Z score of 0.22. This is a bad value and indicates that WALD is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.22, WALD is doing worse than 75.00% of the companies in the same industry.
WALD has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of WALD (0.23) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z 0.22
ROIC/WACCN/A
WACC8.76%
WALD Yearly LT Debt VS Equity VS FCFWALD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.47 indicates that WALD should not have too much problems paying its short term obligations.
WALD has a worse Current ratio (1.47) than 61.11% of its industry peers.
WALD has a Quick Ratio of 1.47. This is a bad value and indicates that WALD is not financially healthy enough and could expect problems in meeting its short term obligations.
WALD has a worse Quick ratio (0.78) than 63.89% of its industry peers.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 0.78
WALD Yearly Current Assets VS Current LiabilitesWALD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 20M 40M 60M 80M 100M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 26.82% over the past year.
Looking at the last year, WALD shows a very strong growth in Revenue. The Revenue has grown by 31.30%.
EPS 1Y (TTM)26.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.23%
Revenue 1Y (TTM)31.3%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-42.11%

3.2 Future

Based on estimates for the next years, WALD will show a very strong growth in Earnings Per Share. The EPS will grow by 41.71% on average per year.
WALD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.90% yearly.
EPS Next Y-292.38%
EPS Next 2Y-77.82%
EPS Next 3Y-35.86%
EPS Next 5Y41.71%
Revenue Next Year-2.48%
Revenue Next 2Y7.97%
Revenue Next 3Y11.2%
Revenue Next 5Y17.9%

3.3 Evolution

WALD Yearly Revenue VS EstimatesWALD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
WALD Yearly EPS VS EstimatesWALD Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 0.4 0.6

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for WALD. In the last year negative earnings were reported.
Also next year WALD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WALD Price Earnings VS Forward Price EarningsWALD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WALD Per share dataWALD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

A cheap valuation may be justified as WALD's earnings are expected to decrease with -35.86% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-77.82%
EPS Next 3Y-35.86%

0

5. Dividend

5.1 Amount

WALD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

WALDENCAST PLC-A

NASDAQ:WALD (2/21/2025, 8:00:02 PM)

After market: 3.16 0 (0%)

3.16

-0.03 (-0.94%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)11-20 2024-11-20/amc
Earnings (Next)03-18 2025-03-18/amc
Inst Owners20.71%
Inst Owner Change-98.5%
Ins Owners2.69%
Ins Owner ChangeN/A
Market Cap388.21M
Analysts80
Price Target5.88 (86.08%)
Short Float %0.65%
Short Ratio4.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)3.55%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-7.73%
EPS NY rev (3m)-89.37%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.78
P/FCF N/A
P/OCF N/A
P/B 0.63
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.99
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.78
BVpS5.04
TBVpS-2.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.88%
ROE -14.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 64.9%
FCFM N/A
ROA(3y)-7.83%
ROA(5y)N/A
ROE(3y)-12.54%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.47
Quick Ratio 0.78
Altman-Z 0.22
F-ScoreN/A
WACC8.76%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.23%
EPS Next Y-292.38%
EPS Next 2Y-77.82%
EPS Next 3Y-35.86%
EPS Next 5Y41.71%
Revenue 1Y (TTM)31.3%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-42.11%
Revenue Next Year-2.48%
Revenue Next 2Y7.97%
Revenue Next 3Y11.2%
Revenue Next 5Y17.9%
EBIT growth 1Y-10.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year17.44%
EBIT Next 3Y23.85%
EBIT Next 5Y37.21%
FCF growth 1Y63.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y64.98%
OCF growth 3YN/A
OCF growth 5YN/A